Aim. The aim of the study was to investigate the prevalence of comorbid conditions in young and middleaged patients with psoriatic arthritis. Material and methods. We analyzed data from the case reports of 84 patients with psoriatic arthritis for 2018-2020, among whom 39 (47,6%) were men and 45 (52,4%) were women, in a course of a cross-sectional observational study. The mean age of the patients was (42,8±10,1) years, DAPSA-18,1 (10,2; 26,7), PASI-5,3 (1,5; 10,8). Results and discussion. Comorbid conditions were observed in 68 (80,9%) patients; the mean number of comorbid conditions was 3 (1; 4). More than one comorbid condition was observed in 69% of the patients. Among transnosological conditions, cardiovascular diseases were the most fre...
The 2021 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment r...
Psoriatic arthritis (PsA) is an inflammatory joint disease (IJD) associated with psoriasis. The clin...
Aim of the work: To evaluate the clinical features and associated comorbidities of psoriatic arthrit...
Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis associated with psoriasis (Ps); ...
AbstractThe aims of this systematic review and meta-analysis were to: (1) describe the prevalence of...
Objectives: to assess the practical clinical value of comorbidities in psoriasis and psoriatic arthr...
The psoriatic disease concept includes psoriasis (PsO) and psoriatic arthritis (PsA). PsO is a chron...
Goal: analysis of comorbidity in patients with various forms of psoriasis. Material and methods. The...
Background: Various studies have shown association of much physical and psychosocial comorbidity wit...
Aim: To identify complications and comorbidities of psoriatic patients. Objective: 1. To evaluate co...
Purpose: Psoriatic arthritis (PsA) is a common type of inflammatory arthritis. Patients with PsA pre...
Rationale: Severe treatment-resistant psoriasis and comorbidities are on the rise.Aim: To evaluate t...
Psoriasis (Ps) and psoriatic arthritis (PsA) are, in addition to skin and osteoarticular lesions, ac...
Objective: Psoriatic arthritis mutilans (PAM) is the most severe phenotype of psoriatic arthritis du...
All around the world, there is growing evidence of the association between psoriasis and comorbiditi...
The 2021 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment r...
Psoriatic arthritis (PsA) is an inflammatory joint disease (IJD) associated with psoriasis. The clin...
Aim of the work: To evaluate the clinical features and associated comorbidities of psoriatic arthrit...
Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis associated with psoriasis (Ps); ...
AbstractThe aims of this systematic review and meta-analysis were to: (1) describe the prevalence of...
Objectives: to assess the practical clinical value of comorbidities in psoriasis and psoriatic arthr...
The psoriatic disease concept includes psoriasis (PsO) and psoriatic arthritis (PsA). PsO is a chron...
Goal: analysis of comorbidity in patients with various forms of psoriasis. Material and methods. The...
Background: Various studies have shown association of much physical and psychosocial comorbidity wit...
Aim: To identify complications and comorbidities of psoriatic patients. Objective: 1. To evaluate co...
Purpose: Psoriatic arthritis (PsA) is a common type of inflammatory arthritis. Patients with PsA pre...
Rationale: Severe treatment-resistant psoriasis and comorbidities are on the rise.Aim: To evaluate t...
Psoriasis (Ps) and psoriatic arthritis (PsA) are, in addition to skin and osteoarticular lesions, ac...
Objective: Psoriatic arthritis mutilans (PAM) is the most severe phenotype of psoriatic arthritis du...
All around the world, there is growing evidence of the association between psoriasis and comorbiditi...
The 2021 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment r...
Psoriatic arthritis (PsA) is an inflammatory joint disease (IJD) associated with psoriasis. The clin...
Aim of the work: To evaluate the clinical features and associated comorbidities of psoriatic arthrit...